Clopidogrel-induced hepatotoxicity and fever

Pharmacotherapy

Volumn 26, Issue 7 I, 2006, Pages 1023-1026

  Ng, Jennifer A ^a   Goldberg, Neil ^b   Tafreshi, Mohammad J ^c  

^a Banner Estrella Medical Center   (United States)

^b Cardiac Solutions   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

Author keywords

Adverse effects; Clopidogrel; Hepatotoxicity fever; Thienopyridines

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CLOPIDOGREL; LIVER ENZYME; TICLOPIDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DRUG MONITORING; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; HOSPITAL DISCHARGE; HUMAN; LIVER TOXICITY; PERCUTANEOUS CORONARY INTERVENTION; SYMPTOMATOLOGY;

EID: 33745726705     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.7.1023     Document Type: Article

References (20)

1. Gent M, Beaumont D, Blanchard J, et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348(9038):1329-39.
2. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358(9281):527-33.
3. Yusuf S, Phil D, Zhao F, et al, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
4. Steinhubl SR, Berger PB, Mann JT, et al, for the Clopidogrel for the Reduction of Events During Observation Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288(19):2411-20.
5. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:483S-512.
6. Antman EM, Anbe DT, Armstrong PW, et al. ACC-AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology-American Heart Association task force on practice guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) 2004. Available from http://www.acc.org/clinical/guidelines/stemi/index.pdf. Accessed May 2005.
7. Braunwald E, Antman EM, Beasley JW, et al. ACC-AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology-American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina) 2002. Available from http://www.acc.org/ clinical/guidelines/unstable/unstable.pdf. Accessed May 2005.
8. Roche Pharmaceuticals. Ticlid (ticlopidine) package insert. Nutley, NJ; 2001.
9. Sanofi-Synthelabo. Plavix (clopidogrel) package insert. New York, NY; 2002.
10. Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000;7:317-18.
11. Beltran-Robles M, Saavedra EM, Sanchez-Munoz D, Romero-Gomez M. Hepatotoxicity induced by clopidogrel. J Hepatol 2004;40:560-1.
12. Duran Q, Jimenez SM, Montero AR, Herrerias-Gutierrez M. Clopidogrel probably induced hepatic toxicity. Med Clin (Barc) 2002;119:37.
13. Andres E, Perrin A, Alt M, Goichot B, Schlienger JL. Febrile pancytopenia associated with clopidogrel. Arch Intern Med 2001;161:125.
14. Anonymous. Drug-induced thrombotic thrombocytopenic purpura. Prescr Int 2001;10(52):50-1.
15. Wolf I, Mouallem M, Rath S, Farfel Z. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc 2003;78:618-20.
16. McCarthy MW, Kockler DR. Clopidogrel-associated leukopenia. Ann Pharmacother 2003;37:216-19.
17. Phillips EJ, Knowles SR, Shear NH. Serum sickness-like reaction associated with clopidogrel [letter]. Br J Clin Pharmacol 2003;56:583.
18. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
19. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89.
20. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.